Clinical Trials Browser

Recruiting × Adenocarcinoma of Lung × 30 days × Clear all

NCT04937283 2026-04-13

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Phase NA Recruiting

Adenocarcinoma of Lung

NCT05198830 2026-04-13

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT05764954 2026-04-09

A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma

Phase 1 Recruiting

Adenocarcinoma of Lung

NCT06181812 2026-04-08

Pathogenic Variants in Genes Associated With Lung Adenocarcinoma

Adenocarcinoma of Lung

NCT07090499 2026-04-07

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Phase 1 Recruiting

GastrointestinalGenitourinaryHead & NeckThoracic

Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Pancreatic Neoplasms

NCT06495125 2026-04-06

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT07481786 2026-04-06

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Phase 3 Recruiting

Adenocarcinoma of Lung, Brain Neoplasms

NCT05665504 2026-04-01

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Adenocarcinoma of Lung

NCT07479095 2026-03-20

KETO-FDG Lung

Phase NA Recruiting

Adenocarcinoma of Lung